Godavari Drugs Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Godavari Drugs Ltd is ₹ 124.95 as of 05 May 15:30 . The P/E Ratio of Godavari Drugs Ltd is 0 as of March 2024 .The P/E Ratio of Shree Ganesh Remedies Ltd is 30.5 as of March 2024 . The Market Cap of Godavari Drugs Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Shree Ganesh Remedies Ltd is ₹ 801.21 crore as of March 2024 . The revenue of Godavari Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shree Ganesh Remedies Ltd for the Dec '25 is ₹ 21.76 crore as compare to the Sep '25 revenue of ₹ 31 crore. This represent the decline of -29.81% The ebitda of Godavari Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shree Ganesh Remedies Ltd for the Dec '25 is ₹ 7.39 crore as compare to the Sep '25 ebitda of ₹ 10.31 crore. This represent the decline of -28.32% The net profit of Godavari Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Shree Ganesh Remedies Ltd changed from ₹ 4.65 crore to ₹ 3.09 crore over 7 quarters. This represents a CAGR of -20.83% The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 17.97 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.

About Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

FAQs for the comparison of Godavari Drugs Ltd and Shree Ganesh Remedies Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or Shree Ganesh Remedies Ltd?

Market cap of Godavari Drugs Ltd is 126 Cr while Market cap of Shree Ganesh Remedies Ltd is 621 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and Shree Ganesh Remedies Ltd?

The stock performance of Godavari Drugs Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and Shree Ganesh Remedies Ltd?

As of May 5, 2026, the Godavari Drugs Ltd stock price is INR ₹124.95. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹484.05.

How do dividend payouts of Godavari Drugs Ltd and Shree Ganesh Remedies Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.